Reporting owner · CIK 0002048497
Hopman Mark
SEC Form 4 history across 1 companies, 7 transactions and 7 filings.
CCOChief Commercial OfficerBeta Bionics, Inc.
Open-market transaction mix0% buys0 buys · 7 sales
Available history · Jun 04, 2026 – Oct 14, 2026
Latest insider transactions
Form 4 filings from available history.| Company | Insider | Activity | Disclosed value | Filed (ET) |
|---|---|---|---|---|
BBNXBeta Bionics, Inc. | Hopman MarkCCO | S · sale10b5-1 detectedSEC filing ↗ | -$13.4kView disclosure → | |
BBNXBeta Bionics, Inc. | Hopman MarkCCO | S · sale10b5-1 detectedSEC filing ↗ | -$7.01kView disclosure → | |
BBNXBeta Bionics, Inc. | Hopman MarkCCO | S · sale10b5-1 detectedAmended filingSEC filing ↗ | -$664kView disclosure → | |
BBNXBeta Bionics, Inc. | Hopman MarkCCO | S · sale10b5-1 detectedSEC filing ↗ | -$619kView disclosure → | |
BBNXBeta Bionics, Inc. | Hopman MarkCCO | S · sale10b5-1 detectedSEC filing ↗ | -$680kView disclosure → | |
BBNXBeta Bionics, Inc. | Hopman MarkCCO | S · saleSEC filing ↗ | -$101kView disclosure → | |
BBNXBeta Bionics, Inc. | Hopman MarkCCO | S · sale10b5-1 detectedSEC filing ↗ | -$3.38kView disclosure → |
Latest Form 4 facts
Quick context from source filings
Latest open-market transaction
sale at Beta Bionics, Inc. on Oct 14, 2026 valued at $13,446.
Review SEC filingLatest buy
No open-market insider purchase is available.
Monthly open-market activity
Last 3 reported months · purchases and sales
View exact monthly values
| Month | Purchases | Sales | Buy value | Sale value | Net value |
|---|---|---|---|---|---|
| Jun 2026 | 0 | 1 | $0.00 | $3,385.25 | -$3,385.25 |
| Sep 2026 | 0 | 4 | $0.00 | $2,066,728.69 | -$2,066,728.69 |
| Oct 2026 | 0 | 2 | $0.00 | $20,461.45 | -$20,461.45 |
Net value is disclosed purchases minus sales, not profit. A dash means the value is unavailable.
Ownership and transaction size
Ownership and ticket size
Average P/S size$298.7K
Median P/S size$101.8K
Direct7
Indirect0
Oct 14, 2026sale
Filing-only signals
Deterministic matches in this insider's history
Associated companies
Companies in the disclosed reporting history
Open-market buy performance
90-day forward return on this insider's open-market purchases
No open-market purchases in available history
A 90-day purchase return requires an open-market buy. No eligible purchases are recorded in this history.
Disclosed ownership
How reported shareholdings evolved
Non-derivative shares held after reported transactions—not stock prices or a complete portfolio.
7 observations · Jun 4, 2026 – Oct 14, 2026. Window ends at the latest available report, not today.
Selected observation · Oct 14, 202655,334 shares reported
Inspect transaction View exact observations and source transactions
| Transaction date | Shares held after | Filed | Source |
|---|---|---|---|
| Jun 4, 2026 | 130,612 | Jun 5, 2026 | View transaction |
| Sep 2, 2026 | 124,027 | Sep 3, 2026 | View transaction |
| Sep 9, 2026 | 87,157 | Sep 10, 2026 | View transaction |
| Sep 9, 2026 | 88,033 | Sep 18, 2026 | Amended transaction |
| Sep 16, 2026 | 56,479 | Sep 17, 2026 | View transaction |
| Oct 1, 2026 | 56,109 | Oct 5, 2026 | View transaction |
| Oct 14, 2026 | 55,334 | Oct 16, 2026 | View transaction |
Securities and direct/indirect ownership contexts are kept separate and never summed. Joint filings may associate the same disclosed row with multiple owners. Unknown values are omitted, not treated as zero. Lines connect observations for readability; they do not establish holdings between filings, cost basis, or current ownership. Amendments and stock splits require reviewing the source.
Hopman Mark Insider Activity FAQ
SEC Form 4 context
Who is Hopman Mark?
Hopman Mark is a reporting owner in SEC Form 4 filings with reporting owner CIK 0002048497.
Which companies has Hopman Mark reported transactions for?
Beta Bionics, Inc.
When was Hopman Mark's latest insider buy?
No open-market insider purchase is available for this period.
When was Hopman Mark's latest insider sale?
sale at Beta Bionics, Inc. on Oct 14, 2026 valued at $13,446.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
The profile shows average and median 90-day stock returns after open-market purchases when price coverage is available. These are unadjusted stock returns, not realized trading gains. Win rates, benchmark-adjusted returns and conviction scores are not calculated.